rs2296241 — CYP24A1

Synonymous coding variant in CYP24A1 (vitamin D 24-hydroxylase) that tags functional haplotypes influencing vitamin D catabolism efficiency and cancer susceptibility

See your personal result for CYP24A1

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

CYP24A1 rs2296241 — A Functional Haplotype Tag in Vitamin D Catabolism

Your body's vitamin D system depends not just on how much vitamin D you take in, but on how fast your cells break it down. CYP24A111 CYP24A1
Cytochrome P450 Family 24 Subfamily A Member 1 — a mitochondrial enzyme that performs the first step in deactivating both circulating 25(OH)D and active 1,25(OH)₂D, converting them to water-soluble calcitroic acid for excretion is the primary off-switch for active vitamin D signaling, expressed in virtually every vitamin D-responsive tissue. The variant rs2296241 is a synonymous coding change22 synonymous coding change
A nucleotide substitution that changes the DNA and mRNA sequence but does not alter the encoded amino acid — here, both GCC and GCT encode alanine at position 184 (c.552C>T, p.Ala184=) that itself does not alter the CYP24A1 protein. Its clinical significance lies in what it marks: it is a well-studied haplotype tag33 haplotype tag
A variant used as a proxy for an entire block of co-inherited DNA variants — because nearby variants are inherited together more often than expected by chance (linkage disequilibrium), a single tag SNP can index an entire multi-variant haplotype for CYP24A1 haplotypes associated with altered enzyme activity, cancer susceptibility, and vitamin D metabolic efficiency.

The Mechanism

CYP24A1 sits within the mitochondrial inner membrane and performs a multi-step oxidation of vitamin D metabolites, initiating their inactivation. The gene sits on chromosome 20q13 and is tightly regulated by vitamin D receptor (VDR)44 vitamin D receptor (VDR)
When active 1,25(OH)₂D binds to VDR, one of the genes VDR upregulates is CYP24A1 itself — creating a negative feedback loop that prevents vitamin D toxicity by accelerating its degradation. Rs2296241 (c.552C>T) is located in exon 6 and sits in strong linkage disequilibrium55 linkage disequilibrium
The tendency of nearby genetic variants to be inherited together as a block, more often than expected if they were independent — creates "haplotypes" where a tag SNP indexes the whole block with other CYP24A1 variants, including rs927650, rs2248137, and rs3787557. These haplotype structures determine CYP24A1's expression level and enzymatic efficiency in different tissues.

Natural inactivating mutations66 Natural inactivating mutations
Rare pathogenic CYP24A1 variants that completely abolish 24-hydroxylase activity cause idiopathic infantile hypercalcemia (IIH) — the opposite problem from accelerated degradation, demonstrating the enzyme's essential homeostatic role in CYP24A1 cause idiopathic infantile hypercalcemia by eliminating the degradation brake entirely. Common variants like rs2296241 operate at the other end of the spectrum — subtle shifts in catalytic efficiency that aggregate across populations into measurable differences in disease risk.

The Evidence

The most structurally important finding comes from the Penna-Martinez et al. thyroid cancer study77 Penna-Martinez et al. thyroid cancer study
Penna-Martinez M et al. Impaired vitamin D activation and association with CYP24A1 haplotypes in differentiated thyroid carcinoma. Thyroid, 2012, which genotyped 253 German differentiated thyroid carcinoma (DTC) patients and 302 healthy controls. The three-marker haplotype rs927650C/rs2248137C/rs2296241G was found in 21.1% of follicular thyroid carcinoma patients vs only 7.3% of controls (P = 1.5×10⁻³) — pointing to the G allele of rs2296241 as part of a risk-conferring CYP24A1 haplotype. The same group found that low circulating 25(OH)D₃ and impaired conversion to active 1,25(OH)₂D₃ correlated with DTC risk, consistent with a haplotype that upregulates CYP24A1 and accelerates vitamin D breakdown.

A meta-analysis of 11 studies88 meta-analysis of 11 studies
Wang P et al. Association of the CYP24A1-rs2296241 polymorphism with hormone-related cancer risk: a meta-analysis. Onco Targets Ther, 2015 involving 5,145 cancer cases and 5,136 controls found rs2296241 associated with significantly reduced prostate cancer risk (additive OR 0.91, 95% CI 0.85–0.97; recessive OR 0.80, 95% CI 0.67–0.95). The A allele appeared protective in prostate cancer — suggesting a different haplotype context in androgen-driven versus thyroid malignancies.

In liver health, a large Chinese case-control study99 large Chinese case-control study
Wang M et al. Genetic Polymorphism of Vitamin D Family Genes CYP2R1, CYP24A1, and CYP27B1 Are Associated With a High Risk of Non-alcoholic Fatty Liver Disease. Front Genet, 2021 (1,114 NAFLD cases, 1,909 controls) found rs2296241 associated with NAFLD risk under the recessive model (OR 1.316, 95% CI 1.048–1.653, p = 0.018). Smaller studies in oral cancer (OR 0.281 for heterozygotes, Zeljic 20121010 Zeljic 2012) and oral lichen planus (OR 0.314, Kujundzic 20161111 Kujundzic 2016) also show significant heterozygote-protective patterns. These findings collectively support rs2296241 as a functionally-relevant marker, though the direction of effect varies by tissue context.

Practical Implications

For the GG genotype — the rarest genotype carrying the derived G allele on both chromosomes — the evidence points toward a CYP24A1 haplotype associated with altered enzyme expression in certain tissues, most consistently linked with thyroid cancer risk in European populations and higher NAFLD susceptibility. Annual vitamin D monitoring is warranted to verify that circulating 25(OH)D levels remain in the optimal range despite any CYP24A1 haplotype-mediated changes in catabolism.

For AG heterozygotes, the picture is reassuring: multiple independent studies find a protective signal in epithelial cancers (oral cavity, esophagus), possibly because a single copy of the G-haplotype produces a dose of altered CYP24A1 activity that optimizes vitamin D signaling in target epithelia without excessive catabolism.

The AA genotype (most common globally) represents the ancestral configuration and is generally associated with the most benign profile across the studied disease endpoints.

Interactions

Rs2296241 is best understood within the full CYP24A1 haplotype context rather than in isolation. Its sister variant rs6013897 — the genome-wide significant GWAS hit from Wang et al. 2010 (Lancet) — represents an independent regulatory signal at the CYP24A1 locus that directly alters serum 25(OH)D levels and supplementation response. Carrying risk alleles at both rs2296241 and rs6013897 would engage two independent CYP24A1 regulatory mechanisms. Additionally, if VDR FokI (rs2228570) or GC (rs4588) variants are present, the combined effect on vitamin D bioavailability is greater than either variant alone. The Penna-Martinez study explicitly measured 25(OH)D and 1,25(OH)₂D levels alongside genotyping, finding that DTC patients with risk haplotypes had impaired activation — linking the haplotype to actual enzymatic phenotype.

Nutrient Interactions

vitamin D altered_metabolism

Genotype Interpretations

What each possible genotype means for this variant.

AA Ancestral Configuration Normal

Most common genotype — ancestral CYP24A1 haplotype baseline

The AA genotype tags the ancestral CYP24A1 haplotype — the configuration present before the G variant arose. In the Penna-Martinez thyroid cancer study, the rs2296241A-containing haplotype was less frequent among follicular thyroid carcinoma patients than controls (particularly for the rs2248137C/rs2296241A combination: 13.1% in papillary carcinoma vs 19.1% in controls, pc=0.04), suggesting a modestly protective signal. In the prostate cancer meta-analysis (Wang 2015), the A allele was associated with lower prostate cancer risk. ClinVar classifies the A allele as benign across three independent submissions.

AG Heterozygous Carrier Intermediate

One copy of the G haplotype — heterozygous for derived CYP24A1 variant

The heterozygote-protective pattern seen in oral cavity studies (Zeljic 2012: OR 0.281 for oral cancer; Kujundzic 2016: OR 0.314 for oral lichen planus) is consistent with heterozygote advantage | A phenomenon where carrying one copy of each allele produces a more advantageous phenotype than either homozygote — observed for some immune and metabolic variants. A plausible mechanism: one copy of the G-haplotype may produce an intermediate CYP24A1 expression level that maintains optimal vitamin D availability in mucosal epithelia. The esophageal cancer study (Yang 2017) also found rs2296241 associated with esophageal squamous cell carcinoma susceptibility in a Chinese cohort, with elevated 25(OH)D being protective. In the Penna-Martinez thyroid cancer data, the rs2248137C/rs2296241A (one A, one G) haplotype combination showed intermediate frequency, consistent with the heterozygous intermediate model.

GG Derived Haplotype Homozygote High Risk

Both copies carry the derived G allele — CYP24A1 risk haplotype homozygote

In the Penna-Martinez thyroid cancer study (n=253 DTC cases), the three-marker haplotype rs927650C/rs2248137C/rs2296241G was found in 21.1% of follicular thyroid carcinoma patients vs only 7.3% of controls (P = 1.5×10⁻³), a strongly significant enrichment. This haplotype combination, which includes rs2296241G, was associated with impaired vitamin D activation — lower 1,25(OH)₂D levels despite normal or low 25(OH)D₃ inputs. The biological interpretation is that elevated CYP24A1 expression (tagged by the G haplotype) accelerates degradation of active vitamin D, reducing the anti-proliferative and pro-differentiation signals vitamin D exerts in thyroid tissue.

The NAFLD association (Wang 2021: OR 1.316, recessive model) adds a liver-health dimension: CYP24A1 is expressed in hepatocytes, and altered enzyme activity in this tissue may modify vitamin D's role in lipid metabolism and inflammatory signaling in the liver.

The prostate cancer meta-analysis (Wang 2015) shows the G allele associated with reduced prostate cancer risk (GG recessive OR 0.80), which is directionally opposite to the thyroid and liver findings — highlighting that rs2296241 haplotype effects are tissue-specific and context-dependent.